Advanced Enzyme Technologies Ltd

Advanced Enzyme Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Advanced Enzyme Technologies Ltd

₹ 367 -0.97%
22 Nov 4:00 p.m.
advancedenzymes.com BSE: 540025 NSE: ADVENZYMES
About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Key Points

Market Position
The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. [1]

Website BSE NSE
  • Market Cap ₹ 4,109 Cr.
  • Current Price ₹ 367
  • High / Low ₹ 571 / 322
  • Stock P/E 28.0
  • Book Value ₹ 120
  • Dividend Yield 1.39 %
  • ROCE 15.2 %
  • ROE 11.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 20.9%

Cons

  • Stock is trading at 3.02 times its book value
  • The company has delivered a poor sales growth of 8.26% over past five years.
  • Company has a low return on equity of 10.6% over last 3 years.
  • Promoter holding has decreased over last 3 years: -9.60%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE SmallCap BSE Healthcare Nifty Total Market Nifty Microcap 250 BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
127 134 132 121 139 142 139 147 158 161 158 155 146
78 85 91 90 99 100 95 103 107 107 102 103 104
Operating Profit 49 49 40 31 40 42 44 44 51 54 55 51 42
OPM % 39% 37% 31% 26% 29% 29% 32% 30% 32% 33% 35% 33% 29%
1 1 3 2 4 9 7 7 6 14 -6 7 10
Interest 0 0 1 1 1 1 1 1 1 1 1 1 1
Depreciation 9 9 9 9 9 9 8 9 9 9 9 9 9
Profit before tax 41 41 34 24 34 40 42 41 48 59 40 49 42
Tax % 27% 31% 26% 26% 23% 31% 24% 29% 27% 28% 25% 28% 21%
30 29 25 18 26 28 32 29 35 42 30 35 33
EPS in Rs 2.66 2.46 2.19 1.60 2.34 2.63 2.87 2.58 3.08 3.74 2.53 3.05 2.94
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
219 239 222 293 329 391 420 444 502 529 541 624 619
130 189 131 155 177 226 236 241 269 327 382 418 417
Operating Profit 90 50 91 138 152 165 184 203 233 203 158 206 203
OPM % 41% 21% 41% 47% 46% 42% 44% 46% 46% 38% 29% 33% 33%
4 1 1 -3 3 1 5 6 9 6 21 21 25
Interest 10 13 9 8 4 9 5 4 3 3 3 4 3
Depreciation 8 10 9 9 13 18 21 26 29 35 35 35 35
Profit before tax 76 28 74 118 137 139 162 179 210 171 140 188 189
Tax % 34% 23% 31% 35% 32% 33% 28% 26% 28% 28% 26% 27%
50 21 51 77 93 94 116 133 151 124 104 137 141
EPS in Rs 4.52 1.85 4.60 6.97 8.20 8.07 9.95 11.58 13.06 10.70 9.45 11.92 12.26
Dividend Payout % 7% 6% 4% 3% 5% 6% 6% 5% 7% 9% 11% 43%
Compounded Sales Growth
10 Years: 10%
5 Years: 8%
3 Years: 8%
TTM: 6%
Compounded Profit Growth
10 Years: 22%
5 Years: 5%
3 Years: 0%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: 17%
3 Years: 3%
1 Year: 14%
Return on Equity
10 Years: 15%
5 Years: 13%
3 Years: 11%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 22 22 22 22 22 22 22 22 22 22 22 22 22
Reserves 140 145 188 256 442 537 657 817 949 1,066 1,213 1,302 1,319
186 167 115 101 54 67 35 28 28 35 34 47 47
48 73 92 71 65 102 91 104 150 137 142 150 161
Total Liabilities 396 406 417 450 583 727 805 971 1,149 1,260 1,411 1,521 1,549
287 287 287 285 421 491 495 563 604 619 649 650 665
CWIP 2 2 5 7 8 11 10 10 10 15 22 41 34
Investments 0 0 0 0 0 0 111 124 121 102 360 403 396
107 117 125 158 153 226 188 275 414 524 380 427 454
Total Assets 396 406 417 450 583 727 805 971 1,149 1,260 1,411 1,521 1,549

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
41 43 54 93 107 116 129 141 163 122 140 141
-40 -25 -15 -10 -60 -60 -124 -43 -27 2 -286 -65
-3 -20 -36 -63 -65 -2 -43 -39 -26 -48 -26 -59
Net Cash Flow -2 -1 2 21 -18 54 -38 60 109 75 -171 17

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 65 49 61 52 55 55 51 61 63 61 68 58
Inventory Days 318 387 403 358 352 339 363 361 346 402 343 375
Days Payable 121 81 89 68 57 78 46 43 56 60 67 40
Cash Conversion Cycle 262 356 374 342 351 315 369 379 353 404 344 393
Working Capital Days 95 5 -4 40 106 82 90 100 104 122 117 106
ROCE % 26% 12% 25% 36% 31% 25% 24% 22% 22% 15% 12% 15%

Shareholding Pattern

Numbers in percentages

4 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
52.71% 52.70% 52.70% 49.88% 49.88% 49.88% 46.52% 45.92% 43.62% 43.50% 43.02% 42.95%
16.39% 18.01% 18.72% 21.68% 21.74% 21.86% 21.89% 22.27% 22.54% 23.01% 12.03% 12.63%
8.99% 6.90% 6.26% 5.60% 5.64% 5.73% 7.58% 6.49% 6.98% 7.56% 8.08% 8.02%
21.91% 22.38% 22.32% 22.86% 22.76% 22.54% 24.02% 25.34% 26.88% 25.95% 36.87% 36.40%
No. of Shareholders 84,34686,57384,37684,27781,18377,53775,05272,64273,03468,64065,22266,758

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls